Post-natal development of type 1 cannabinoid receptor immunoreactivity in the rat hippocampus

被引:45
作者
Morozov, YM
Freund, TF
机构
[1] Hungarian Acad Sci, Inst Expt Med, H-1083 Budapest, Hungary
[2] INSERM, INMED, U29, F-13258 Marseille, France
关键词
cholecystokinin; dentate gyrus; inhibition; interneuron; parvalbumin;
D O I
10.1046/j.1460-9568.2003.02852.x
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Type 1 cannabinoid receptors, selectively located on axon terminals of GABAergic interneurons in the hippocampus, are known to be involved in endocannabinoid-mediated retrograde synaptic signalling. The question arises whether type 1 cannabinoid receptors appear on these axons during early post-natal life, when GABAergic transmission is still depolarizing, and whether there are any developmental changes in the cellular or subcellular expression pattern. Here we demonstrate, using single and double immunocytochemical methods at the light and electron microscopic levels, that type 1 cannabinoid receptors are expressed only on the membrane of axon terminals and pre-terminal axons but not on the soma-dendritic membrane at all examined timepoints between postnatal days 0 and 20, similar to the adult distribution. All type 1 cannabinoid receptor-positive boutons formed symmetric synapses. Granular labelling in the somata was already strong at post-natal day 0 and corresponded to multivesicular bodies, lysosomes, Golgi apparatus and rough endoplasmic reticulum. The type 1 cannabinoid receptor-positive axons were shown to originate largely from cholecystolkinin-immunoreactive basket and bistratified neurons throughout the hippocampus (90% of all type 1 cannabinoid receptor-containing cells) and dentate gyrus (70% of all type 1 cannabinoid receptor-containing cells). The remaining cells have not been identified but probably belong to the somatostatin- and/or neuropeptide Y-containing subsets, as cholecystokinin-negative, type 1 cannabinoid receptor-positive axons have been observed in strata moleculare and lacunosum-moleculare of the dentate gyrus and CA1-3, respectively, where these neurons are known to arborize. No cell types were found that expressed type 1 cannabinoid receptors transiently at some developmental stage. We conclude that the cellular and subcellular pattern of type 1 cannabinoid receptor expression during early post-natal life is similar to the adult pattern and type 1 cannabinoid receptors are expressed on the cholecystokinin-containing axons as soon as synapse formation begins. This suggests that retrograde synaptic signalling by endocannabinoids is required for the normal operation of GABAergic neurotransmission even before it becomes hyperpolarizing.
引用
收藏
页码:1213 / 1222
页数:10
相关论文
共 41 条
  • [1] Alger BE, 2002, PROG NEUROBIOL, V68, P247
  • [2] Excitatory actions of GABA during development: The nature of the nurture
    Ben-Ari, Y
    [J]. NATURE REVIEWS NEUROSCIENCE, 2002, 3 (09) : 728 - 739
  • [3] THE POSTNATAL-DEVELOPMENT OF CHOLECYSTOKININ-LIKE ACTIVITY IN THE BRAIN AND SMALL-INTESTINE OF THE RAT
    BRAND, SJ
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 1982, 326 (MAY): : 425 - 433
  • [4] Cholecystokinin-immunopositive basket and Schaffer collateral-associated interneurones target different domains of pyramidal cells in the CA1 area of the rat hippocampus
    Cope, DW
    Maccaferri, G
    Marton, LF
    Roberts, JDB
    Cobden, PM
    Somogyi, P
    [J]. NEUROSCIENCE, 2002, 109 (01) : 63 - 80
  • [5] REGIONAL DISTRIBUTION OF CHOLECYSTOKININ MESSENGER-RNA IN RAT-BRAIN DURING DEVELOPMENT - QUANTITATION AND CORRELATION WITH CHOLECYSTOKININ IMMUNOREACTIVITY
    DEBELLEROCHE, J
    BANDOPADHYAY, R
    KING, A
    MALCOLM, ADB
    OBRIEN, K
    PREMI, BP
    RASHID, A
    [J]. NEUROPEPTIDES, 1990, 15 (04) : 201 - 212
  • [6] Diffuse transmission by acetylcholine in the CNS
    Descarries, L
    Gisiger, V
    Steriade, M
    [J]. PROGRESS IN NEUROBIOLOGY, 1997, 53 (05) : 603 - 625
  • [7] Dupuy ST, 1996, J NEUROSCI, V16, P6919
  • [8] Dupuy ST, 1997, J COMP NEUROL, V389, P402
  • [9] Dupuy-Davies S, 1999, HIPPOCAMPUS, V9, P186, DOI 10.1002/(SICI)1098-1063(1999)9:2<186::AID-HIPO9>3.0.CO
  • [10] 2-B